Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

API Manufacturing: SOP for Residual Solvent Testing by GC – V 2.0

Posted on By

API Manufacturing: SOP for Residual Solvent Testing by GC – V 2.0

Standard Operating Procedure for Residual Solvent Testing by Gas Chromatography in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/125/2025
Supersedes SOP/API/125/2022
Page No. Page 1 of 9
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To define the procedure for the determination and quantification of residual solvents in Active Pharmaceutical Ingredients (APIs) using Gas Chromatography (GC), ensuring compliance with ICH Q3C and applicable pharmacopeial limits.

2. Scope

This SOP is applicable to all QC analysts performing residual solvent testing on raw materials, intermediates, and finished APIs using headspace or

direct injection gas chromatography techniques.

3. Responsibilities

  • QC Analyst: Prepare samples, standards, and run GC analysis as per validated method.
  • QC Reviewer: Verify chromatograms, peak integration, and calculated values against limits.
  • QA Officer: Ensure compliance with documentation and data integrity requirements.
See also  API Manufacturing: SOP for Equipment Cleaning and Validation in Solvent Units - V 2.0

4. Accountability

The QC Head is accountable for ensuring timely and accurate testing of residual solvents, proper qualification of GC instruments, and training of analysts.

5. Procedure

5.1 Sample and Standard Preparation

  1. Prepare standard solutions using certified residual solvent reference standards as per STP.
  2. Prepare sample solutions using suitable diluent (e.g., DMSO, DMF, water) under specified conditions.
  3. Use headspace vials for volatile solvent extraction; seal with crimp caps.

5.2 Instrument Setup

  1. Use qualified GC system equipped with FID or TCD detector and headspace or autosampler.
  2. Check the following:
    • Column: Capillary column suitable for residual solvent separation
    • Carrier gas flow rate and pressure
    • Oven temperature program as per method
    • Injection volume and split ratio

5.3 System Suitability

  1. Run system suitability test using standard mixture.
  2. Acceptance criteria:
    • Resolution ≥ 1.5 between critical pairs
    • RSD of peak area ≤ 15% for replicate injections
    • Retention time repeatability within ±5%
See also  API Manufacturing: SOP for LOD Testing During Drying Stage - V 2.0

5.4 Sample Analysis

  1. Inject the sample solution as per sequence defined in the test method.
  2. Record chromatograms and identify residual solvent peaks based on retention times.
  3. Quantify using external standard calibration or area normalization method.

5.5 Calculation and Reporting

  1. Calculate concentration of each solvent using calibration curve or response factor.
  2. Compare against ICH Q3C and pharmacopoeial permissible limits (Class 1, 2, or 3 solvents).
  3. Report result as:
    • Below detection limit (BDL) if peak not observed
    • Pass/Fail based on specification compliance

5.6 Disposal and Cleanup

  1. Dispose residual solvent standards, sample remains, and headspace vials as per hazardous waste SOP.
  2. Clean GC injection port, liner, and column after analysis if contamination is suspected.

6. Abbreviations

  • GC: Gas Chromatography
  • FID: Flame Ionization Detector
  • TCD: Thermal Conductivity Detector
  • BDL: Below Detection Limit
  • LOD: Limit of Detection
  • LOQ: Limit of Quantification
  • QA: Quality Assurance
  • QC: Quality Control
See also  API Manufacturing: SOP for Work-Up Procedure After Reaction Completion - V 2.0

7. Documents

  1. Residual Solvent Testing Worksheet (Annexure-1)
  2. System Suitability Checklist
  3. Sample Preparation Logbook

8. References

  • ICH Q3C – Impurities: Guideline for Residual Solvents
  • USP <467> – Residual Solvents
  • 21 CFR Part 211 – US FDA GMP Guidelines

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Residual Solvent Testing Worksheet

Date Sample Name Batch No. Solvent Result (ppm) Limit (ppm) Status
13/04/2025 API-A API-20250413 Methanol 220 300 Pass
13/04/2025 API-A API-20250413 Toluene BDL 890 Pass

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial SOP Issue Regulatory Requirement QA Head
13/04/2025 2.0 Included headspace mode and disposal steps Audit Observation QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Analytical Method Development: HPLC Method Development for Finished Product – V 2.0
Next Post: Elixir Department: SOP for Homogeneity Verification – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version